Cost Minimization Of Using Activated Prothrombin Complex Concentrate Versus Recombinant Activated Factor Vii In Patients With A Nd B Hemophilia In Presence Of Inhibitors
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.500
https://www.valueinhealthjournal.com/article/S1098-3015(16)31867-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
474
First Page :
A433
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31867-8&doi=10.1016/j.jval.2016.09.500